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The Saccharomyces cerevisiae origin recognition com-
plex (ORC) is composed of six subunits and is an essen-
tial component in the assembly of the replication appa-
ratus. To probe the organization of this multiprotein
complex by electron microscopy, each subunit was
tagged on either its C or N terminus with biotin and
assembled into a complex with the five other unmodi-
fied subunits. A nanoscale biopointer consisting of a
short DNA duplex with streptavidin at one end was used
to map the location of the N and C termini of each
subunit. These observations were made using ORC free
in solution and bound to the ARS1 origin of replication.
This mapping confirms and extends previous studies
mapping the sites of subunit interaction with origin
DNA. In particular, we provide new information con-
cerning the stoichiometry of the ORC-ARS1 complex
and the changes in conformation that are associated
with DNA binding by ORC. This versatile, new approach
to mapping protein structure has potential for many
applications.
The replication of eukaryotic DNA is dependent upon the
timely and accurate formation of a series of multiprotein as-
semblies. The earliest of these events is the selection of poten-
tial sites for replication initiation within the genomic DNA. In
bacteria, bacteriophages, and eukaryotic viruses this task is
mediated by initiator proteins (1). In addition to identifying
where to start replication, many initiator proteins facilitate the
unwinding of the DNA helix at the replication origin and the
recruitment of proteins that are needed to make a functional
replisome (2).
It is widely accepted that the initiator for eukaryotic repli-
cation is the origin recognition complex (ORC)1 (3). ORC was
originally identified through its ability to bind to a conserved
11-bp sequence found at all Saccharomyces cerevisiae origins of
replication called the autonomously replicating sequence (ARS)
and autonomous consensus sequence (ACS) (reviewed in Ref.
4). These sequences are part of larger (100–150 bp) replication
origins that include at least two other AT-rich elements (B1
and B2, see Refs. 5–7). ORC is composed of six subunits that
are named in order of their relative size (Orc1–Orc6, largest to
smallest). Although the replication origin structure in S. cer-
evisiae is more defined than that of many other eukaryotic
organisms, ORC-related complexes have been identified and
shown to be essential for DNA replication in many eukaryotic
organisms including S. cerevisiae, Schizosaccharomyces pombe,
Drosophila melanogaster, Xenopus laevis, and humans (re-
viewed in Ref. 8). Thus, ORC is likely to be a universal feature
of eukaryotic DNA replication.
The interaction between ORC and DNA is a complex ATP-
regulated event. Of the six ORC subunits, only Orc6 is dispen-
sable for DNA binding (9). DNA cross-linking studies indicate
that of the remaining five subunits four are in direct contact
with origin DNA (Orc1, Orc2, Orc4, and Orc5). ORC binding to
origin DNA requires ATP binding by its largest subunit, Orc1
(10). Orc1 is a slow ATPase that is inhibited when ORC binds
to the ACS element of origin DNA. ORC also binds to ssDNA in
a length-dependent but sequence- and ATP-independent man-
ner (11). The minimum length of ssDNA ORC can bind is 30
bases, and the affinity increases until it reaches a maximum for
sequences over 80 bases. Most interestingly, ssDNA stimulates
ORC ATP hydrolysis with the same length dependence.
Electron microscopic studies of ORC suggest that its confor-
mation changes depending on the DNA to which it is bound.
When ORC is visualized by itself or bound to origin DNA, it
appears to have two major globular domains (similar to a
peanut shell) (11) (Fig. 1A). In contrast, ORC bound to ssDNA
assumes a bent conformation (similar to a cashew) (11). Al-
though the consequences of these changes in conformation are
unknown, they could represent an altered ability of ORC to
interact with other DNA replication factors or other interme-
diates in the replication initiation process.
To investigate further the architecture of ORC, it would be
desirable to map the location of the six ORC subunits in the
peanut-shaped particle and relate this information to previous
DNA binding data. We initiated such a study by using antibod-
ies tagged with gold particles, but we found that these gold
antibody particles were too large to provide the needed resolu-
tion. Furthermore, this approach relied on the availability of
high specificity antibodies with a low background of nonspecific
binding. Thus, in a complex such as ORC, it would be difficult
to obtain six different antibodies each with the same specificity
and affinity. The requirement for different antibodies for each
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subunit also makes gold antibody probes ill-suited to compare
the relative accessibility of one subunit over another on the
surface of the particle. These limitations led us to consider a
more ideal nanoscale probe (which we will refer to as a bio-
pointer) as follows: 1) would be simple to generate in ample
amounts; 2) would have dimensions allowing visualization by
routine EM preparative methods, although not being so large
as to obscure its target; 3) would have a distinct appearance; 4)
would have a high affinity for the target and a low background
of nonspecific binding to DNA or proteins; and 5) could be used
for different samples.
In this study we describe the design and synthesis of a novel
DNA biopointer that satisfies these requirements and its use in
mapping the location of the S. cerevisiae ORC subunits. The
approach relies on the high affinity biotin-streptavidin associa-
tion and methods to engineer proteins with peptide tags at their
N or C termini which become biotinylated in vivo by biotin ligases
when the proteins are expressed in bacteria (12–14), yeast (15),
or insect cells (16). The biopointer itself is constructed from a
179-bp DNA to which a single streptavidin tetramer is bound at
one end. The short DNA-streptavidin biopointer is easily distin-
guished by EM and has a relatively small cross-section and hence
does not obscure its target. In this study we describe the use of
this biopointer to map the relative location of ORC subunits
within the complex in the presence and absence of origin DNA.
Our findings have important implications for the stoichiometry of
ORC bound to DNA and the conformational changes that occur
during DNA binding.
EXPERIMENTAL PROCEDURES
Biotinylated ORC Complexes—To generate ORC complexes with a
single subunit biotinylated at its C or N terminus, the last 88 residues
of the acetyl-CoA carboxylase, BCCP subunit (SMEAPAAAEISGHIV-
RSPMVGTFYRTPSPDAKAFIEVGQKVNVGDTLCIVEAMKMMNQI-
EADKSGTVKAILVESGQPVEFDEPLVVIE) (17), plus a two-amino
acid linker (GG) were placed on either the C or N terminus of each ORC
subunit, and that ORC subunit along with the remaining five non-
tagged subunits were expressed in insect cells (18) and purified as
described (9).
Biopointers—A 179-bp region of pBluescript® II S/K () phagemid
vector (Stratagene, Inc.) between the T7 and T3 promoters was ampli-
fied by PCR using a 20-nucleotide biotinylated oligonucleotide (5-bio-
AAT TAA CCC TCA CTA AAG GG-3), which overlies the T3 promoter,
and a 22-oligonucleotide (5-GTA ATA CGA CTC ACT ATA GGG C-3),
which overlies the T7 promoter. The resulting DNA fragments were
extracted twice with phenol/chloroform, precipitated with ethanol, and
resuspended in 10 mM Tris-HCl, pH 7.5, 1 mM EDTA (TE). The DNA
fragment was further purified by electrophoresis on a 1% agarose gel
run in 90 mM Tris base, 90 mM boric acid and eluted from the gel using
a Qiacut kit (Qiagen). To form the biopointers, 1 g of the DNA in TE
was incubated with a 4-fold molar excess of streptavidin tetramers
(Invitrogen) for 20 min at room temperature. Excess streptavidin was
removed by filtration through a Clontech (Palo Alto, CA) Chroma-
SpinTE-100 column using the procedure specified by the manufac-
turer. For some preparations, DNA lacking bound streptavidin and
dimers consisting of two DNAs bound to a single streptavidin were
removed by banding in a CsCl density gradient for 36 h at 58,000 rpm
at an average density of 1.6 g/ml.
DNA Containing the ARS1 Sequence—pARS1WT plasmid DNA (11)
was digested with SpeI and EcoRV to generate a 2.2-kb fragment that
contained the ARS1 sequence and was purified as described by Lee and
Bell (9).
Formation of ORC-Biopointer and ORC-Biopointer-DNA Com-
plexes—Biopointers were incubated with purified ORC particles in 50
l of binding buffer (20 mM HEPES-KOH, pH 7.6, 2 mM EDTA, 5 mM
magnesium acetate, 0.15 M KCl) containing 100 M ATP, 530 fmol of
ORC (based on a molecular weight of 414,600 Da), and 1360 fmol of
biopointers (based on a molecular mass of 184,100 Da). Following an
overnight incubation at 4 °C, the samples were fixed with glutaralde-
hyde (0.6% final concentration) for 5 min at room temperature and then
filtered through a Chroma-SpinTE-100 column. Mixtures of ORC and
the DNA fragment containing the ARS1 were incubated in 50 l of
binding buffer, containing 138 fmol of ORC, 138 fmol of the dsDNA, and
100 M ATP at room temperature for 10 min. Glutaraldehyde was then
added to a final concentration of 0.3% for 3 min at room temperature,
followed by filtration through a Chroma-SpinTE-100 column. To 50 l
of elution buffer, 1360 fmol of biopointers was added and the mixture
gently rocked overnight at 4 °C.
Electron Microscopy—The complexes above were adsorbed to thin
carbon foils, washed, air-dried, and rotary shadowcast with tungsten at
high vacuum (19). Samples were examined in a Phillips CM12 at 40 kV.
Images of a large number of tagged ORC complexes for analysis were
captured digitally using a Gatan 794 CCD camera attached to the CM12
and Digital Micrograph 3.3 (Gatan Inc., Pleasanton, CA). Images for
publication were captured on sheet film, scanned with a Nikon LS4500
film scanner, the contrast optimized, and panels arranged using Adobe
Photoshop software.
RESULTS
Generating a Nanoscale Biopointer—The biopointer gener-
ated here consisted of a 179-bp DNA containing biotin at one
end to which a single streptavidin tetramer is bound. DNA of
this length is relatively straight and is easily visualized by
tungsten shadowcasting methods utilized to visualize DNA-
protein complexes. The DNA is produced by PCR amplification
with one DNA primer being modified with an attached biotin.
To place streptavidin at the end of the DNA, the DNA was
incubated with a 4–10-fold molar excess of streptavidin tet-
ramers for 1 h at room temperature, and the unbound strepta-
vidin was removed by gel filtration and/or CsCl density band-
ing (see “Experimental Procedures”).
Electron microscopy confirmed the largely monomeric nature
of the streptavidin coupling protocol. As shown in Fig. 1B, one
end of the DNA, but never both, was bound by a protein particle
whose size was consistent with that of a single streptavidin
tetramer (based on mass estimates from previous studies).
Following CsCl density banding fractions could be obtained
approaching 99% monomeric biopointers with a low contami-
nation of dimers (two DNAs bound to a single streptavidin) or
DNA rods without streptavidin (as scored by EM, n  500).
Visualization of S. cerevisiae ORC Associated with a Bio-
pointer—To map the relative location of the ORC subunits, two
variants of each of the S. cerevisiae ORC subunits were pro-
duced, one containing an 87-amino acid sequence at the C
terminus and one with this tag at the N terminus. This se-
quence, a fragment of the Escherichia coli biotin carboxyl car-
rier protein (BCCP), was identified as a target for in vivo
biotinylation (17). When expressed in insect cells, this tag is
efficiently biotinylated (18). Twelve different ORC variants
were generated (termed ORC1C, ORC1N, ORC2C, etc. to indi-
cate a single biotin incorporated into the C or N terminus of
just one of the six subunits) by co-infecting insect cells with five
viruses, each expressing a nontagged subunit, and a sixth virus
expressing an ORC subunit with the 87-amino acid tag at one
end. These modified complexes were purified to homogeneity,
and following incubation with streptavidin, the gel mobility
shift assays indicated that greater than 90% of the particles
contained biotin (data not shown).
To measure the level of nonspecific binding of the biopoint-
ers, untagged ORC was incubated with a 2-fold molar excess of
biopointers for 24 h at 4 °C. The samples were fixed and un-
bound biopointers removed by gel filtration chromatography.
Following preparation for EM (see “Experimental Procedures”)
only 1.8% (n  106) of the ORC molecules had a biopointer
attached. In contrast, 31% (n  134) of complexes that included
a C-terminal Orc4 tag had an associated biopointer. The bio-
pointer detected approximately the same percentage of com-
plexes for the remaining 11 biotin-modified ORCs. Because
long incubations were required for optimal binding of the bio-
pointers to DNA-bound ORC, similar 24-h incubations were
used for biopointer binding to DNA-free ORC. However, effi-
cient binding of the biopointers to free ORC particles was
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observed after a 15-min incubation at room temperature (data
not shown).
Examples of three different ORC variants with biopointers
attached are shown in Fig. 1C at higher magnification, and a
gallery of all 12 variants is shown in Fig. 2. ORC particles
appeared bilobed as reported previously (11) (Fig. 1, A and C,
and Fig. 2). Inspection of many images suggested that there is
significant flexibility between the two lobes at the site of at-
tachment. The two lobes appear joined asymmetrically so that
as they lie on the EM support one long surface (denoted as the
top) is “smooth” and the other surface (termed the bottom) has
the shape of a rounded “w” (Fig. 1A, left). Following incubation
with biopointers and preparation for EM, DNA tails were ob-
served originating from the ORC particles at a single site (Fig.
1C and Fig. 2). The DNA tails exited ORC at different angles
but never looped back. Examples could be seen in which the
DNA rod was short, suggesting that ORC was lying over the
biopointer. There was no indication that the biopointers ori-
ented ORC in any one position on the EM grids.
Mapping the Location of ORC Subunits Using Biopointers—
Because ORC has a distinct peanut-like shape with a top and
bottom, mapping the point where the biopointers attach pro-
vides the potential for determining the location of each subunit
within the particle. At least 50 examples of each of the 12
biotin-modified ORCs with biopointers attached were collected.
To be included in the analysis the biopointers had to be nearly
full length (to eliminate images in which ORC was lying on top
of the biopointer), and the ORC particle had to have a bilobed
morphology with a top and bottom. Because ORC was not
bound to DNA in these experiments (see below), there was no
means of determining left from right, but the smooth “top” and
the w-shaped bottom surfaces provide a means of distinguish-
ing one long surface from the other. As illustrated in Fig. 3A,
the ORC particle was divided into four segments around the
first half of a compass circle, (0–45, 46–90, 91–135, and 136–
180o). Each ORC with a biopointer was placed in one of these
four segments, and radial histograms were generated to pro-
vide a “radar view” (Fig. 3B). It is noteworthy that in only one
case (ORC6C) was the percentage of complexes with two bio-
pointers attached significantly above (2-fold) the background
level (3–6%) of dimer biopointers in the background, and
ORC6N was within this background level. This suggests that
other than the possibility of ORC6, these subunits are present
in only a single copy per complex. Furthermore, the results
with DNA-bound ORC (see below) suggest that complexes with
two ORC6 subunits may be nonfunctional.
As shown in the radar views, in several cases such as 1C, 4N,
and 5C the distributions are narrow. In contrast, the locations
determined for 2N, 3N, and 5N were broader, suggesting that
these ends of these subunits were less tightly constrained. In
general, the C-terminal distributions mapped close to the same
quadrant as the N-terminal distributions.
Visualization and Mapping of ORC Subunit Location When
Bound to Origin DNA—-Observation of ORC bound to origin
DNA offered an opportunity to gain additional information
concerning the relative location of subunits within the complex
and relative to the bound origin DNA. To this end, we repeated
the experiments described above with ORC bound to a single
copy of the ARS1 origin of replication located asymmetrically
within a DNA fragment. ARS1 is located 33% from the nearest
end of the fragment tested with the B elements located adja-
cent to the short end and the ACS adjacent to the long end (Fig.
4). Use of the biopointer in this context can address two impor-
tant issues. First, although previous EM studies suggest that
only one ORC binds to ARS1, the number of biopointers at-
tached to each ORCARS1 complex will definitively determine
how many ORC molecules are bound at ARS1 (and by exten-
sion other origins). Second, the presence of the asymmetric
FIG. 1. Visualization of ORC bound to a nano-scale biopoint-
ers. A, following fixation, purified ORC particles were prepared for EM
by mounting onto thin carbon foils, washing, and rotary shadowcasting
with tungsten (“Experimental Procedures”). B, nano-scale biopointers
consisting of a 179-bp DNA with a single streptavidin tetramer bound
at one end were generated (“Experimental Procedures”) and prepared
for EM without fixation as above. Free balls are individual streptavidin
tetramers present prior to removal by gel filtration. C, biotin can be
placed at either the C or N terminus of one of the six ORC subunits with
the other five subunits nonbiotinylated (see “Experimental Proce-
dures”). Incubation of biotinylated ORC with the biopointers resulted in
an association at a specific site. The biotinylated subunit is indicated
the upper right corner of each panel and shown in reverse contrast. Bar
is equivalent to 250 (A), 675 (B), and 200 bp (C).
FIG. 2. Gallery of biotinylated ORC variants associated with
biopointers. Each of the 12 biotinylated ORC variants was incubated
with the biopointers and prepared for EM as in Fig. 1. The subunit
number is shown to the left of each pair, and the C or N terminus
designation is at the top. Bar equals a length of DNA equivalent to
200 bp.
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ARS1 DNA in these images allows the subunit location to be
mapped relative to the elements of the origin.
To map the location of individual ORC subunits when bound
to ARS1 DNA, equimolar amounts of ORC and DNA were
mixed at room temperature for 10 min and lightly fixed. At the
ratio of ORCs to DNA used, only 33% of the DNA molecules
were bound to ORC. Of the DNA molecules with ORC bound,
roughly one-third appeared to be bound to the ARS1 sequence
FIG. 3. Radar view map of bio-
pointer location on the ORC. From the
micrographs of free ORC we cannot dis-
tinguish left from right, but we can dis-
tinguish a smooth top surface from a low-
ercase w-shaped bottom surface. ORC was
divided into four domains starting from
the top of the molecule (domain I),and
ending at the bottom (domain IV). A, to
generate a radar view for each biotinyla-
tion site, the location at which a bio-
pointer was attached was determined
from electron micrographs as in Fig. 2
and placed in one of the four domains. B,
to determine the percentage of biopoint-
ers associated within a particular do-
main, the number counted for each do-
main was divided by the total number of
biopointers scored. The gray area of each
radar view indicates the overall location
to which all of the biopointers were
mapped. The axial spokes define each do-
main area.
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(33% from one end). The remaining ORC-bound DNAs were
split equally between those with ORC bound away from ARS1
and those that were bound to more than one ORC molecule.
Biopointers were never seen attached to the untagged ORC.
When ORC was modified with biotin, however, we observed
frequent association with a single biopointer (Fig. 4B and Fig.
5; Table I). We never observed a situation in which two bio-
pointers were associated with ORC bound at the origin. The
absence of such molecules strongly supports the hypothesis
that ORC binds as a monomer to ARS1 and that there is only
one copy of each subunit within the bound complexes.
A gallery of micrographs of ARS1-bound ORC for each of the
12 different variants is shown in Fig. 5. In some cases the DNA
was highly bent around the ORC (Fig. 5, 3N, 5N, and 4C), but
in other examples the DNA path was relatively straight (Fig. 5,
1C, 4N, and 6C). With long DNA arms used here, if the ORC
binds to the support prior to the DNA arms, fluid flow can
result in the DNA arms folding around the protein complex.
Inspection of many examples did not show any consistent tend-
ency for the ORC-proximal DNA to be bent, but bending of 45o
or less could have been overlooked.
The efficiency of the biopointers attaching to a DNA-bound
ORC was different for the 12 different ORC variants (Table I).
This is in contrast to the situation when ORC was not bound to
DNA in which case the efficiency was roughly the same for all
12 variants with 30–35% of each ORC variant associated
with the biopointer. In general the larger subunits (Orc1p,
Orc2p, and Orc3p) were recognized by the biopointers more
efficiently than the smaller subunits. The exception was the
smallest subunit Orc6p, which was recognized as well as the
larger subunits. Generally the efficiency of binding to the C or
N termini was similar; however, there were marked differences
for Orc2p and Orc5p. These differences in efficiency of bio-
pointer binding most likely reflect the extent to which each
terminus is buried in the ORC complex. Because this difference
is more pronounced when ORC is bound to DNA, it suggests
that either bound DNA or conformation changes in ORC upon
DNA binding result in reduced accessibility of several of the
termini.
A comparison of the ability of the biopointers to bind to a
specific terminus when ORC was free in solution versus DNA
bound could provide information about which subunit termini
are blocked by DNA binding. To make this comparison, the
tagged ORC variants were incubated with the ARS1-contain-
ing DNA fragment, and the sample was then lightly fixed and
biopointers added. We then compared the fraction of free ORC
associated with biopointers to the fractions of ARS1-bound
ORC that were similarly associated. The results (Table II) show
that in all cases DNA-bound ORC associated with the bio-
pointer less efficiently than free ORC. Furthermore, there was
a large variation in biopointer association efficiency depending
on which ORC variant was tested. These findings suggested
that DNA binding does mask some termini more than others.
When the same comparison was made, including all DNA-
bound ORCs (not just those at the ARS1), similar values were
obtained (data not shown). This argues that the ORC makes
similar contacts with DNA when it is bound away from the
origin.
Using the smooth top and the w-shaped bottom surface of the
ORC particle along with the asymmetric location of ORC along
the DNA as a means to distinguish left from right, the point at
which each biopointer was attached to ARS1-bound ORC was
determined for at least 20 examples per ORC variant. As illus-
trated in Fig. 6, ORC was divided into eight 45o segments
around the compass circle. Each DNA-bound ORC with a bio-
pointer attached was placed in one of these eight segments, and
radial histograms were generated to provide a radar view (Fig.
6). In several cases (1N, 4N, and 5N) the distributions are
narrow as contrasted to 2N, 4C, and 6C that are broader. In
general the C-terminal distributions map to the same radial
segments as the N-terminal distributions. For example, the
patterns of 5C and 5N overlap and map to similar radial
wedges, suggesting that this subunit is locked into a single site
on ORC with both termini being in close proximity. On the
other hand, the distribution for 4N is narrow, whereas the
distribution for 4C is broad, suggesting that whereas the N
terminus may be specifically localized, the C terminus may be
flexible and able to assume different positions over the surface
of ORC.
DISCUSSION
In this study a novel EM procedure has been developed to
map the location of the six subunits of the S. cerevisiae ORC.
Each subunit was modified in vivo on either its C or N terminus
with biotin and assembled into a complex with the five other
unmodified subunits. A nanoscale biopointer consisting of a
short stiff DNA with streptavidin at one end that could be seen
in the EM was used to map the location of the C and N termini
of each subunit in ORC. This was done for ORC free in solution
FIG. 4. ORC bound to ARS1 DNA. Biopointers were incubated with
complexes of ORC bound to a 2.2-kb fragment containing the ARS1
element located 33% from one end. A, ORC was not biotinylated. B, the
C terminus of Orc4p was biotinylated. The placement of the B3, B2, B1,
and ACS regions within the ARS1 element (white box) are denoted
above the ARS1 element. ARS1 divides the DNA fragment into a short
side (S) and a long side (L). Bar equals a length of DNA equivalent to
500 bp.
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and bound to DNA at the ARS1 origin of replication. The
results of the mapping correspond well to previous chemical
footprinting. More importantly, these findings provide new in-
formation concerning the stoichiometry of the ORC-ARS1 DNA
complex and support a model in which substantial conforma-
tional changes occur as ORC associates with origin DNA.
The biopointers are easily generated in ample amounts using
PCR and a set of DNA primers, one of which is biotinylated. By
using tungsten shadowcasting, the biopointers were easily dis-
tinguished from ORC and, in the case of DNA-bound ORC, from
the bound ARS1 DNA. The background of nonspecific binding
of biopointers to nonbiotinylated ORCs was less than 2% at
physiologic salt, and the biopointers should work well with
other EM preparative methods. In studies by Nossal et al.,2
biopointers were used to identify the presence and location of
several bacteriophage T4 replication proteins within an active
T4 replication complex and to estimate copy number. This
2 N. Nossal, A. Makhov, P. D. Chastain II, and J. D. Griffith,
unpublished data.
TABLE I
Efficiency of biopointers labeling ARS1 bound ORCs
ORCs containing biotin on one terminus of a single subunit were
incubated with the ARS1 containing DNA fragment. For ORC bound to
ARS1 (33% from the nearest end), the presence or absence of a bio-
pointer was scored to determine the efficiency of association.
FIG. 5. Gallery of ORC complexes at the ARS1 associated with the biopointers. Complexes of each of the 12 ORC variants were formed
with the 2.2-kb fragment containing ARS1 as in Fig. 4, incubated with the biopointers, and prepared for EM as in Fig. 1. The biotinylated subunit
is indicated in each panel. The DNA-bound ORC is oriented such that the short side of the DNA fragment is on the left side of each micrograph.
The bar equals a length of DNA equivalent to 500 bp.
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approach opens the door to both detection of a protein in a
multiprotein complex and quantitative measurements of copy
number and relative accessibility of each subunit to the sur-
face. An additional advantage is that a single preparation of
biopointers can be used for different biotinylated proteins as
contrasted to gold antibody probes that must be generated
anew for each target. Biopointers can also be used to map sites
on RNA molecules to which biotinylated oligonucleotides are
annealed, as revealed by Fouche et al.3 in which the telomerase
template region of yeast TLC1 RNA was localized by using a
biopointer.
When ORC was bound to ARS1 DNA, significant differences
in the fraction of particles associated with a biopointer were
observed depending on which subunit and which terminus
contained the biotin. As shown in Table I, there was a greater
than 8-fold difference depending on whether the biotin was on
the C terminus of Orc2p (high binding) or the C terminus of
Orc4p (low binding). There was also a 3-fold difference for
Orc2p between the C terminus (high) and N terminus (low).
Specifically, the ability of the biopointer to recognize its target
was high (41–47% of the ORCs bound to DNA contained a
biopointer) for ORC2C and ORC3C, lower (25–30%) for
ORC1C, ORC1N, ORC3N, ORC5N, ORC6N, and ORC6C, (25–
30%), and much lower (6–14%) for ORC2N, ORC4N, and
ORC5C (Table I). These quantitative differences must reflect
the relative accessibility of each biotinylated terminus to the
biopointers, and thus provide a measure of the degree to which
each terminus is either buried within ORC or lies at or near the
surface of the particle. These data provide another level of
structural information that can be derived by using biopointers
that could not be obtained by using conventional gold antibody
probes. Furthermore, it can be correlated with footprinting
studies as described below.
In these experiments roughly 1/2 and 1/3 of the tagged
ORC4N and ORC6C variants, respectively, had two biopointers
attached (based on the observation above that roughly 30% of
the 12 variants were tagged with a biopointer). Although this
may suggest that a fraction of ORC reconstituted in vivo con-
tains multiple copies of Orc4p and Orc6p, if so we would have
expected to observe a higher frequency of double tagging for the
opposite termini of the same two subunits. A second observa-
tion that calls into question the dimeric nature of these sub-
units is that none of the ORC variants showed significant
double labeling when ORC was bound to ARS1 DNA (see be-
low), suggesting that particles with multiple copies of any
subunit were excluded from DNA binding. Despite this, the
interactions observed could represent potential interactions
between subunits that could occur if more than one ORC were
present at the origin at some point during the replication
process.
The location of the subunit termini as determined by the
biopointer approach correlates with and adds to previous ORC-
DNA cross-linking studies (9). In these studies a cross-linker
was placed at a variety of specific positions along ARS1 DNA,
and the ORC subunits that were within 10 Å of the cross-
linker were determined. This analysis provided a map of the
subunits adjacent to each tested position. Consistent with
these previous studies, we observed that both termini of Orc5
and the C terminus of Orc6 are located near the B-element side
of ARS1. Similarly, biopointer localization indicates that the
Orc1 and Orc2 N termini localize to the ACS end of ARS1,
which is also consistent with the earlier cross-linking studies.
These studies also add to these previous observations. Because
the cross-linking studies can only monitor the parts of ORC
adjacent to the DNA, they are unable to look more fully at the
distribution of the proteins throughout the complex. For exam-
ple, although the cross-linking studies indicated that the Orc6
subunit is restricted to the B-element side of ORC bound to
ARS1 DNA, the analysis with the biopointer suggests that
Orc6 reaches between the two lobes of ORC. Similarly, Orc1
also appears to reach across the two lobes, despite being tightly
restricted to the ACS side of ARS1-bound ORC in the protein-
DNA cross-linking studies.
A second strong point of the biopointer approach is the abil-
ity to provide information concerning the stoichiometry of the
protein-DNA complex. Although previous studies of ORC inter-
actions with origin DNA generally supported the idea that a
single ORC complex is bound to each origin (9, 11), in no case
has this been shown definitively. The presence of only a single
biopointer per ORC complex associated with origin DNA pro-
vides strong evidence that a single ORC is associated with each3 N. Fouche, D. Zappulla, T. Cech, and J. Griffith, unpublished data.
TABLE II
Ability of the biopointers to label a biotinylated ORC
To compare the relative availability of an ORC subunit terminus for the biopointers when ORC was free in solution or bound to ARS1, ORCs
containing biotin on one terminus of a single subunit were incubated with DNA containing ARS1. Fields of molecules contained ORC particles that
were both bound to ARS1 and free in solution. In such fields the number of ORC particles that were labeled with a biopointer for these two classes
was counted. ORC that was not bound to ARS1 was not included in this scoring.
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origin. Similarly, these studies also support the hypothesis that
there is only one copy of each subunit in each complex.
Comparison of the location of ORC subunits with and with-
out ARS1 DNA also suggests that some subunit termini change
their locations significantly when bound to DNA. For example,
the C terminus of Orc1 moves from a well defined “lower”
position within the complex in the absence of ARS1 to a more
distributed position in the “upper” portion of ORC when it
FIG. 6. Radar view map of bio-
pointer location on biotinylated ORC
bound to ARS1. A, ORC bound to ARS1
was divided into eight equal 45o segments
around the compass circle. The top and
bottom designations are as in Fig. 5, and
the side of ORC adjacent to the short seg-
ment of the DNA was placed on the left.
Each of the 12 ORC variants was incu-
bated with DNA followed by addition of
biopointers and preparation for EM as in
Fig. 5. B, to generate a radar view map for
each tagged variant, the location where a
biopointer was attached was determined
from electron micrographs as in Fig. 5
and placed in one of the eight domains. At
least 20 examples were scored for each
map. The number of molecules scored for
each domain was divided by the total
number scored to determine the percent
of molecules within that domain. The
gray area of each radar view indicates the
overall location to which all of the bio-
pointers were mapped. The axial spokes
define each domain.
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binds DNA. In contrast, the C terminus of Orc2 moves from the
upper to the lower portion of ORC upon DNA binding. Both of
these findings support a model in which the conformation of
ORC is altered significantly upon DNA binding. Such changes
could facilitate binding of other replication proteins to ORC
only when it is bound to origin DNA or it could regulate other
activities of ORC that are altered when bound to origins (i.e.
ATPase activity).
Together, these studies illustrate the power of using a well
defined molecular pointer to characterize proteins and protein-
DNA complexes by using electron microscopy. A significant
limitation in this particular study arose from the apparent
2-fold symmetry of ORC, which made it impossible to distin-
guish between the left and right sides of ORC when free in
solution. Furthermore, the distribution of pointer placement in
some of the radar plots was broad thus making a precise
determination of the subunit location difficult. Even with these
limitations, our study has illustrated the potential of this ap-
proach to determine subunit stoichiometry and to provide in-
sights into the general location of individual proteins in a
larger complex. A major hurdle was the need to modify the
target proteins or DNA with biotin. Although in this study the
modification was performed in vivo after the addition of a
78-amino acid biotinylation tag to each subunit, in other in-
stances chemical modification of specific residues (e.g. Cys)
could be used to accomplish the same outcome. Smaller amino
acid tags have now been identified (12) that could be used in
place of the 88-amino acid sequence used here. Recently one of
us (J. D. G.) generated C-terminal biotinylated TRF1 protein in
insect cells using a 13-amino acid tag that was biotinylated
when E. coli biotin ligase was co-expressed in the insect cells.
In the future other temporal orders of coupling the pointer
DNA to streptavidin may prove useful. In our work2 on T4
replication complexes, we found that a higher level of tagging
could be achieved if free streptavidin was first incubated with
the replication complexes containing a biotinylated T4 DNA
polymerase, followed by removal of the free streptavidin and
then adding the pointer DNA. Finally, this general approach
could be extended to generate biopointers specific for other
protein epitopes (e.g. hexahistidine) We are constructing such a
pointer at this time. The ability to double label complexes, for
example by using a hexahistidine-specific pointer with a 300-
bp-long DNA tail and a biotin-specific pointer with a 179-bp
tail, would add greatly to the general power of this approach.
We anticipate that the use of these nanoscale pointers will be
applicable to many other situations, including the analysis of
more complex assemblies of multiple proteins and DNA/RNA
and higher resolution EM.
Acknowledgment—We thank Jeff Gelles for providing a plasmid con-
taining the C-terminal fragment of E. coli BCCP used in the biotin
modification studies.
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